Quin Wills

CSO, Ochre Bio

Unspecified

About

Male

Quin is an MD and computational biologist. He founded his first liver drug company 15 years ago, co-steered Oxford's single-cell genomics consortium, and founded the Cellular and Systems Genomics department for a leading biopharma

Experience

Ochre Bio

CSO

View →

YC W20Series A67Oxford, Oxfordshire, United KingdomBiotech/Pharma · Health Care

Ochre Bio

CSO

View →

YC W20Series A67Oxford, Oxfordshire, United KingdomBiotech/Pharma · Health Care

Education

University of Oxford

Headlines from Google News. Social posts load from the platform only when you open a tab.

Meet the man trying to eradicate the need for liver transplants
The Times · Jul 19
How human-first datasets are reshaping AI drug discovery
Labiotech.eu · Jun 25
Derisking clinical trials requires a ‘human first’ approach
Longevity.Technology · Oct 23
This company aims to end the need for liver transplants — as thousands die every year on the waitlist
New York Post · Oct 21
Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics development
Pharmafile · Jun 30

People at Ochre Bio

Jack O'Meara

Founder

View all at Ochre Bio →

Data from: yc, crunchbase